POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Investigator Site #1064, Erie

Investigator Site #1085, Hagerstown

Investigator Site #1083, Durham

Investigator Site#1066, Nashville

Investigator Site #1084, Nashville

Investigator Site #1086, Oak Park

Investigator Site #1078, Plano

Investigator Site#1075, Bellaire

Investigator Site #1074, Katy

Investigator Site#1068, Lakewood

Investigator Site #1073, Los Angeles

Investigator Site #1072, Los Angeles

Investigator Site#1065, Beverly Hills

Investigator Site #1080, Palo Alto

Investigator Site #1079, Sacramento

Investigator Site #1069, Waltham

Investigator Site #1076, Palisades Park